MedPath

Sinus floor augmentation with microstructured BCP granules

Recruiting
Conditions
Maxillary sinus floor augmentation, sinus pneumatization, maxillary atrophy, maxillaire sinusbodem elevatie, maxillaire atrophy, sinus penumatisatie
Registration Number
NL-OMON29673
Lead Sponsor
niversity Medical Center Utrecht, Department of Oral and Maxillofacial Surgery & Special Dentistry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Male or female patients aged 18-75 years

- Patient is willing to give informed consent to participate in the study

Exclusion Criteria

- Maxillary sinus pathology

- Presence of a local or systemic disease or treatment affecting bone formation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of new bone formation in the augmented sinus floor by histomorphometrical analysis of biopsy specimens at 5 months of follow up.
Secondary Outcome Measures
NameTimeMethod
- Implant survival rate and adverse events during 17 months of follow up.<br /><br>- Augmented bone height as measured by CBCT at 5, 11 and 17 months of follow up.<br /><br>- Implant stability quotient (ISQ) as measured by resonance frequency analysis (RFA) at 5 months (primary stability) and 11 months of follow-up.<br /><br>- Scoring of gingival index, supra-gingival plaque index, and dichotomous bleeding index 17 months after surgery.<br /><br>- Probing depth of implant and adjacent teeth (buccal, palatinal, distal, mesial) at 17 months after surgery. <br /><br>- Pain by the Visual Analogue Scale (VAS-score)<br>
© Copyright 2025. All Rights Reserved by MedPath